查詢結果分析
相關文獻
- Carteolol (Arteoptic[feb9])之臨床評估及心血管作用--內因性擬交感神經作用之探討
- Timoptol-XE[feb9] 及Timoptol[feb9] 用於青光眼或高眼壓症病人之比較性研究
- 除了降眼壓之外,還有沒有其他方法?談青光眼病人的飲食
- Corneal Opacity and Congenital Glaucoma Associated with Massive Heparan Sulfaturia: Report of One Case
- 碳酸酐酶抑制劑6-Hydroxyethoxy-2-benzothiazole Sulfonamide靜脈注射後之兔眼藥物動力學
- 碳酸酐酶抑制劑6-Hydroxyethoxyzolamide局部點眼後之兔眼藥物動力學
- 抑制細胞增生藥物在青光眼濾過造口術的應用
- 雅鉻雷射虹膜穿孔術於急性隅角閉鎖性青光眼的臨床結果
- 藥物導致的青光眼
- Dorzolamide(Trusopt[feb9])--第一個Carbonic Anhydrase Inhibitor眼滴劑
頁籤選單縮合
題 名 | Carteolol (Arteoptic[feb9])之臨床評估及心血管作用--內因性擬交感神經作用之探討=Clinical Evaluation and Cardiovascular Effects of Carteolol (Arteoptic[feb9])--The Role of ISA |
---|---|
作 者 | 陳美如; 周清光; 劉榮宏; | 書刊名 | 中華民國眼科醫學會雜誌 |
卷 期 | 38:1 1999.03[民88.03] |
頁 次 | 頁50-56 |
分類號 | 418.2323 |
關鍵詞 | 內因性擬交感神經作用; 青光眼; 降眼壓藥; Glaucoma; Carteolol; Intraocular pressure; ISA; |
語 文 | 中文(Chinese) |
中文摘要 | Carteolol(Arteoptic��)是目前唯一具有ISA(內因性擬交感神經作用)的非選擇 性β阻斷劑。本篇試驗對象為原先點用 0.5% Timolol 的 POAG 患者 13 名及從未曾點藥的 NTG 患者 13 名,經篩選後開始點用 2% Carteolol,一日兩次。 分別於用藥前、用藥後第 2,4,8,12 週進行眼部檢查,並測量眼壓、收縮壓、舒張壓、脈搏及記錄自覺症狀。結果 予以記錄並做統計分析。我們發現 POAG 患者改用 2% Carteolol 後眼壓仍能維持良好的控 制, 而 NTG 患者的眼壓於使用 4, 8, 12 週後分別下降 2.8、1.3 及 1.OmmHg,降幅為 7-19%,連統計學上的意義。不論 POAG 或 NTG 患者,點藥後的血壓均有下降的情形,收縮 壓平均下降 4 ∼ 11 毫米汞柱,舒張壓則為 2 ∼ 8 毫米汞柱。 而在脈搏方面,兩組降低 的幅度皆在每分鐘心跳降低 3 次的範圍內。 不管是收縮壓、舒張壓或是脈搏,兩組的降幅 並不具有統計學上的意義。 相較於國內外文獻有關非選擇性β阻斷劑 (Timolol) 造成的血 壓降低。心跳變慢等嚴重副作用的報告,Carteolol 對於全身性心血管作用的影響較小,對 於年紀大,心肺功能較差,或是高危險群的 NTG 患者來說,應是較佳的選擇。 |
英文摘要 | Carteolol(Arteoptic��)is the only non- selective Beta-blocker with ISA(lntrinsic Sympathomimetic Activity) now. Thrirteen POAG patients under 0.5% Timolol and thirteen NTG without treatment patients were enrolled in this study. All patients had complete eye examinations and systemic vital signs checkup before and after Carteolol use. IOP, SBP, DBP, PR, subjective symptoms were taken in the visits scheduled at 2,4,8,12 weeks with data recorded and analysed. After 12 weeks therapy, Carteolol reduced IOP approximately 7-19% in patients with NTG with statistically significance and achieved good IOP control in patients with POAG. The reduction of SBP ranged between 4 and 11 mmHg and DBP between 2 and 8 mmHg while the PR reduction was less than 3 bprn. No statistically significant difference was found in the SBP, DBP and PR in both groups. Most patients reported no subjective symptoms except few gritty sensation and transient blurred vision. Beta-adrenergic antagonists with ISA have been shown to cause less systemic cardiovascular effects in literatures. Therefore, they may be useful in patients in whom old aged, bradycardia, poor cardiovascular function, or high risk NTG is a Problem. |
本系統中英文摘要資訊取自各篇刊載內容。